Kyverna Therapeutics, Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

8.87

+0.10 (1.14%)

At close: Apr 2, 2026, 4:00 PM EDT

9.04

+0.17 (1.92%)

After-hours: Apr 2, 2026, 6:32 PM EDT

Kyverna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	124.09	96.62	34.65	37.74	76.07
Short-Term Investments	155.16	189.36	22.9	13.59	-
Cash & Short-Term Investments	279.25	285.98	57.54	51.32	76.07
Cash Growth	-2.35%	396.98%	12.12%	-32.53%	-
Other Current Assets	3.7	4.62	3.12	1.93	1.02
Total Current Assets	282.95	290.6	60.66	53.25	77.09
Net Property, Plant & Equipment	5.42	10.66	10.61	12.44	7.81
Other Long-Term Assets	5.45	3.39	3.92	1.23	0.59
Total Assets	293.83	304.65	75.2	66.92	85.49
Accounts Payable	5.31	4.62	4.36	1.45	0.77
Accrued Expenses	27.21	25.19	12.58	8.23	8.34
Current Portion of Leases	3.97	3.94	2.92	2.28	0.81
Unearned Revenue	-	-	-	-	6
Total Current Liabilities	36.49	33.76	19.86	11.95	15.93
Long-Term Debt	24.74	-	-	-	-
Long-Term Leases	0.32	4.3	6.16	8.29	4.74
Other Long-Term Liabilities	-	-	-	0.01	2.35
Total Long-Term Liabilities	25.06	4.3	6.16	8.29	7.09
Total Liabilities	61.55	38.06	26.02	20.25	23.02
Common Stock	0	-	-	-	-
Additional Paid-in Capital	657.01	530	4.64	1.71	0.53
Accumulated Other Comprehensive Income	0.1	0.11	0	-0.03	-
Retained Earnings	-424.83	-263.52	-136.04	-75.68	-46.78
Total Common Shareholders' Equity	232.28	266.59	-131.4	-74	-46.25
Minority Interest	-	-	180.57	120.67	108.72
Shareholders' Equity	232.28	266.59	49.18	46.68	62.47
Total Liabilities & Equity	293.83	304.65	75.2	66.92	85.49
Total Debt	29.03	8.24	9.08	10.56	5.56
Net Cash (Debt)	250.22	277.74	48.46	40.76	70.51
Net Cash Growth	-9.91%	473.08%	18.91%	-42.20%	-
Net Cash Per Share	5.65	7.25	71.94	89.48	0.27
Book Value	232.28	266.59	-131.4	-74	-46.25
Book Value Per Share	5.25	6.95	-195.06	-162.46	-0.17
Tangible Book Value	232.28	266.59	-131.4	-74	-46.25
Tangible Book Value Per Share	5.25	6.95	-195.06	-162.46	-0.17

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q